Hannah Beba
@HannahBeba
Followers
3K
Following
14K
Statuses
6K
Consultant Pharmacist for Diabetes. West Yorkshire & Leeds Health and Care Partnership. Co-Chair DUK Healthcare Prof Advisory Committee. PCDS committee member.
Leeds, England
Joined July 2016
Our West Yorkshire Guideline for CKD approved today at APC. This guidance should help us screen, refer & optimise care for people living with CKD. Thank you to all the brilliant minds who contributed and to Andrew Frankel and the imperial team for the inspiration
5
27
93
RT @parthaskar: IMPORTANT: Drug safety update on GLP-1 & dual GIP/GLP-1 agonists -relevance to anaesthesia via @MHRAgovuk Especially in l…
0
25
0
RT @GoggleDocs: Amycretin: “New kid on the block”❓ 🔹 Phase 1b/2a trial shows amycretin, a dual GLP-1/amylin receptor agonist ⤵️ body wei…
0
17
0
RT @GoggleDocs: Finerenone on kidney outcomes in HFmrEF/HFpEF❗️ 🔹 FINEARTS-HF trial: Reduced new-onset macroalbuminuria by 38% (HR: 0.62)…
0
26
0
RT @GoggleDocs: Finerenone: Do we need another treatment for #CKD in #T2D ❓ 🔹 Reduces CKD progression by 23% & CV events by 14% (FIDELITY…
0
52
0
RT @EASOobesity: EASO proposes an updated framework for diagnosing, staging, and managing adult obesity, aligning it with the concept of ob…
0
16
0
RT @GoggleDocs: Microdosing semaglutide ⤵️ GI side effects etc... 🔹 Tailored dosing via multidose pens allows for gradual escalation to im…
0
21
0
RT @GoggleDocs: Early-stage #type1diabetes ⤴️ focus on early detection & care❗️ 📍 New UK consensus guidelines highlight: 🔸Screening for is…
0
6
0
RT @parthaskar: An excellent read around GLP-1 receptor agonists- their role in #Diabetes and as a topic of more recent discussion? #Obesit…
0
14
0
RT @GoggleDocs: Finerenone ⤵️ CV death & HF events in HFpEF with #obesity❗️ 🔹 FINEARTS-HF trial: Benefits consistent across BMI categories…
0
13
0
Fantastic news to end the year with Sunil ! Screening appropriately is the first essential step to ensuring people living with CKD get the care they need .. looking forward to doing more exciting work around renal health in 2025 !!
0
1
4
RT @parthaskar: Much 'excitement' about 'Anti-Obesity' drugs Without changing mindsets, structures, archaic "tiers", & of course suppli…
0
16
0
0
0
1
@GrahamStretch @PNewlandJones @Ines_VFonseca @drnkan 😂 I think you do need to see it in person to fully appreciate it
0
0
2
@ejii_emmanuel @PNewlandJones @Ines_VFonseca @drnkan Always happy to support great people ! You are a joy to know :)
0
0
1
1
0
3
0
0
2
RT @PNewlandJones: Lovely catch up with @HannahBeba @Ines_VFonseca @drnkan for diabetes pharmacist meeting in Manchester.
0
2
0
RT @GoggleDocs: SGLT2i vs. DPP-4i ⤴️ PAD surgical risk in veterans with #type2diabetes 🔹 SGLT2i 18% ⤴️ risk of amputations or revasculari…
0
10
0